Meghmani Organics Ltd
Founded in 1986 as M/s Gujarat Industries, the company was incorporated in 1995 as Meghmani Organics Limited. The company manufactures Pigments and Agrochemicals through its 6 manufacturing facilities located in Gujarat. The company is amongst the top 3 Phthalocyanine based pigment players in the world and amongst the top 10 producers of pesticides in India.[1]Meghmani Organics Ltd (MOL) manufactures green and blue pigment products, which are used to manufacture printing ink, plastic, paints, textiles, leather, and rubber.
It also manufactures a wide variety of commonly used pesticides for crop and non-crop applications, this include insect control in wood preservation and food grain storage.
- Market Cap ₹ 2,082 Cr.
- Current Price ₹ 81.8
- High / Low ₹ 104 / 71.7
- Stock P/E
- Book Value ₹ 60.1
- Dividend Yield 1.71 %
- ROCE -3.08 %
- ROE -6.63 %
- Face Value ₹ 1.00
Pros
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of 9.26% over last 3 years.
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.37.7 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
700 | 1,637 | 2,498 | 2,553 | 1,566 | |
595 | 1,353 | 2,119 | 2,211 | 1,587 | |
Operating Profit | 105 | 283 | 379 | 342 | -20 |
OPM % | 15% | 17% | 15% | 13% | -1% |
130 | 30 | 102 | 114 | 38 | |
Interest | 18 | 11 | 9 | 66 | 46 |
Depreciation | 22 | 51 | 63 | 77 | 92 |
Profit before tax | 194 | 252 | 409 | 313 | -121 |
Tax % | 23% | 26% | 26% | 24% | 12% |
150 | 186 | 304 | 238 | -106 | |
EPS in Rs | 29,914.00 | 37,296.00 | 11.97 | 9.35 | -4.17 |
Dividend Payout % | 17% | 19% | 12% | 15% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -1% |
TTM: | -39% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -147% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -2% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 9% |
Last Year: | -7% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | 25 | 25 | 25 | 25 | 25 |
Reserves | 961 | 1,148 | 1,441 | 1,644 | 1,502 |
264 | 268 | 499 | 824 | 837 | |
407 | 533 | 832 | 705 | 676 | |
Total Liabilities | 1,657 | 1,974 | 2,798 | 3,198 | 3,040 |
481 | 634 | 911 | 1,166 | 1,164 | |
CWIP | 101 | 112 | 188 | 356 | 509 |
Investments | 191 | 304 | 211 | 183 | 114 |
885 | 924 | 1,487 | 1,494 | 1,253 | |
Total Assets | 1,657 | 1,974 | 2,798 | 3,198 | 3,040 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
22 | 333 | 65 | 204 | 250 | |
13 | -307 | -133 | -418 | -178 | |
-26 | -14 | 58 | 234 | -85 | |
Net Cash Flow | 8 | 12 | -10 | 21 | -14 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Debtor Days | 241 | 92 | 79 | 75 | 101 |
Inventory Days | 271 | 152 | 161 | 158 | 185 |
Days Payable | 209 | 137 | 144 | 108 | 176 |
Cash Conversion Cycle | 302 | 106 | 96 | 124 | 109 |
Working Capital Days | 239 | 89 | 99 | 113 | 138 |
ROCE % | 19% | 24% | 16% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
9h - Audio recording of Earning Call of Q4 FY2024 Financial Results
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
14h - Copy of Newspaper publication for Q4FY24 results
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
2d - Press Release on Financial Results for Q4 and FY2024
-
Announcement under Regulation 30 (LODR)-Investor Presentation
2d - Investor Presentation on Financial Results for Q4 and FY2024
- FINANCIAL RESULTS FOR F.Y.2024. 2d
Annual reports
Concalls
-
May 2024TranscriptNotesPPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Jan 2023Transcript PPT
-
Jan 2023TranscriptNotesPPT
-
Oct 2022Transcript PPT
-
Jul 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021TranscriptPPT
-
Nov 2021Transcript PPT
-
Oct 2021TranscriptNotesPPT
-
Aug 2021Transcript PPT
Business Overview
The Company’s operation includes manufacture and marketing of technical, intermediates and formulation of Crop Protection Chemicals for its Agro-Chemicals segment and Phthalocyanine Green 7, Copper Phthalocyanine Blue (CPC), Alpha Blue and Beta Blue for its Pigments segment. [1]